These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 29624806

  • 1. Krüppel-like factor 4 promotes c-Met amplification-mediated gefitinib resistance in non-small-cell lung cancer.
    Feng W, Xie Q, Liu S, Ji Y, Li C, Wang C, Jin L.
    Cancer Sci; 2018 Jun; 109(6):1775-1786. PubMed ID: 29624806
    [Abstract] [Full Text] [Related]

  • 2. Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification.
    La Monica S, Caffarra C, Saccani F, Galvani E, Galetti M, Fumarola C, Bonelli M, Cavazzoni A, Cretella D, Sirangelo R, Gatti R, Tiseo M, Ardizzoni A, Giovannetti E, Petronini PG, Alfieri RR.
    PLoS One; 2013 Jun; 8(10):e78656. PubMed ID: 24167634
    [Abstract] [Full Text] [Related]

  • 3. Marsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cells.
    Han SY, Zhao MB, Zhuang GB, Li PP.
    Lung Cancer; 2012 Jan; 75(1):30-7. PubMed ID: 21757251
    [Abstract] [Full Text] [Related]

  • 4. Addition of S-1 to the epidermal growth factor receptor inhibitor gefitinib overcomes gefitinib resistance in non-small cell lung cancer cell lines with MET amplification.
    Okabe T, Okamoto I, Tsukioka S, Uchida J, Hatashita E, Yamada Y, Yoshida T, Nishio K, Fukuoka M, Jänne PA, Nakagawa K.
    Clin Cancer Res; 2009 Feb 01; 15(3):907-13. PubMed ID: 19188161
    [Abstract] [Full Text] [Related]

  • 5. Anti-tumor activity of WK88-1, a novel geldanamycin derivative, in gefitinib-resistant non-small cell lung cancers with Met amplification.
    Jang WJ, Jung SK, Kang JS, Jeong JW, Bae MK, Joo SH, Park GH, Kundu JK, Hong YS, Jeong CH.
    Cancer Sci; 2014 Oct 01; 105(10):1245-53. PubMed ID: 25117641
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET.
    Zhou JY, Chen X, Zhao J, Bao Z, Chen X, Zhang P, Liu ZF, Zhou JY.
    Cancer Lett; 2014 Sep 01; 351(2):265-71. PubMed ID: 24983493
    [Abstract] [Full Text] [Related]

  • 7. Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3.
    Shou J, You L, Yao J, Xie J, Jing J, Jing Z, Jiang L, Sui X, Pan H, Han W.
    Cancer Lett; 2016 Aug 28; 379(1):124-33. PubMed ID: 27264264
    [Abstract] [Full Text] [Related]

  • 8. MiR-130a overcomes gefitinib resistance by targeting met in non-small cell lung cancer cell lines.
    Zhou YM, Liu J, Sun W.
    Asian Pac J Cancer Prev; 2014 Aug 28; 15(3):1391-6. PubMed ID: 24606471
    [Abstract] [Full Text] [Related]

  • 9. Licochalcone B inhibits growth and induces apoptosis of human non-small-cell lung cancer cells by dual targeting of EGFR and MET.
    Oh HN, Lee MH, Kim E, Yoon G, Chae JI, Shim JH.
    Phytomedicine; 2019 Oct 28; 63():153014. PubMed ID: 31323446
    [Abstract] [Full Text] [Related]

  • 10. Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT.
    Yang J, Qin G, Luo M, Chen J, Zhang Q, Li L, Pan L, Qin S.
    Cell Death Dis; 2015 Jul 23; 6(7):e1829. PubMed ID: 26203858
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung Cancer.
    Zhen Q, Liu J, Gao L, Liu J, Wang R, Chu W, Zhang Y, Tan G, Zhao X, Lv B.
    Cytogenet Genome Res; 2015 Jul 23; 146(1):1-8. PubMed ID: 26184032
    [Abstract] [Full Text] [Related]

  • 12. Butein, a novel dual inhibitor of MET and EGFR, overcomes gefitinib-resistant lung cancer growth.
    Jung SK, Lee MH, Lim DY, Lee SY, Jeong CH, Kim JE, Lim TG, Chen H, Bode AM, Lee HJ, Lee KW, Dong Z.
    Mol Carcinog; 2015 Apr 23; 54(4):322-31. PubMed ID: 24974831
    [Abstract] [Full Text] [Related]

  • 13. miR-19a contributes to gefitinib resistance and epithelial mesenchymal transition in non-small cell lung cancer cells by targeting c-Met.
    Cao X, Lai S, Hu F, Li G, Wang G, Luo X, Fu X, Hu J.
    Sci Rep; 2017 Jun 07; 7(1):2939. PubMed ID: 28592790
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells.
    Li A, Cao W, Liu X, Zhang Y, Ma Y, Xu R, Zhang R, Liu X, Zhou S, Wang R, Liu J, Tang X.
    J Cancer Res Clin Oncol; 2020 Jul 07; 146(7):1737-1749. PubMed ID: 32342201
    [Abstract] [Full Text] [Related]

  • 16. Relationship between long non-coding RNA PCAT-1 expression and gefitinib resistance in non-small-cell lung cancer cells.
    Wang S, Liu C, Lei Q, Wu Z, Miao X, Zhu D, Yang X, Li N, Tang M, Chen Y, Wang W.
    Respir Res; 2021 May 12; 22(1):146. PubMed ID: 33980216
    [Abstract] [Full Text] [Related]

  • 17. MiR-128 reverses the gefitinib resistance of the lung cancer stem cells by inhibiting the c-met/PI3K/AKT pathway.
    Jiang J, Feng X, Zhou W, Wu Y, Yang Y.
    Oncotarget; 2016 Nov 08; 7(45):73188-73199. PubMed ID: 27690301
    [Abstract] [Full Text] [Related]

  • 18. Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance.
    Cretella D, Saccani F, Quaini F, Frati C, Lagrasta C, Bonelli M, Caffarra C, Cavazzoni A, Fumarola C, Galetti M, La Monica S, Ampollini L, Tiseo M, Ardizzoni A, Petronini PG, Alfieri RR.
    Mol Cancer; 2014 Jun 05; 13():143. PubMed ID: 24898067
    [Abstract] [Full Text] [Related]

  • 19. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.
    Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, Lindeman N, Gale CM, Zhao X, Christensen J, Kosaka T, Holmes AJ, Rogers AM, Cappuzzo F, Mok T, Lee C, Johnson BE, Cantley LC, Jänne PA.
    Science; 2007 May 18; 316(5827):1039-43. PubMed ID: 17463250
    [Abstract] [Full Text] [Related]

  • 20. Dual inhibition of EGFR and MET by Echinatin retards cell growth and induces apoptosis of lung cancer cells sensitive or resistant to gefitinib.
    Oh HN, Lee MH, Kim E, Kwak AW, Seo JH, Yoon G, Cho SS, Choi JS, Lee SM, Seo KS, Chae JI, Shim JH.
    Phytother Res; 2020 Feb 18; 34(2):388-400. PubMed ID: 31698509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.